Skip to main content
GILD
NASDAQ Life Sciences

Gilead Praises Collaborative Push for Lenacapavir HIV Prevention Launch in South Africa

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$130.68
Mkt Cap
$160.386B
52W Low
$104.46
52W High
$157.29
52W Position info
25% above low
Off High info
17% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

GILD sits 25% above its 52-week low of $104.46 on elevated volume (2.2× avg).

Summary

Gilead Sciences is supporting collaborative efforts to launch its HIV prevention drug, Lenacapavir, in South Africa. This development signals progress in expanding market access for a key Gilead product in a region with a high demand for HIV prevention. While the headline emphasizes the collaborative aspect, it indicates a positive step towards broader availability and potential revenue contribution for the company.

At the time of this announcement, GILD was trading at $130.68 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $160.4B. The 52-week trading range was $104.46 to $157.29. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

GILD - Latest Insights

GILD
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $174.57
Real-time Price: $166.64 info
Change: -$7.93 (-5%) info
Market Cap: $207.844B info
GILD
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $165.88
Real-time Price: $166.64 info
Change: +$0.760 (+0.46%) info
Market Cap: $207.844B info
GILD
Oct 29, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $164.00
Real-time Price: $166.64 info
Change: +$2.64 (+2%) info
Market Cap: $207.844B info
GILD
Oct 22, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $157.19
Real-time Price: $166.64 info
Change: +$9.45 (+6%) info
Market Cap: $207.844B info
GILD
Oct 19, 2026, 6:40 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $156.82
Real-time Price: $166.64 info
Change: +$9.82 (+6%) info
Market Cap: $207.844B info